States must now report how they prevent opioid-treatment drug misuse

What it does

This bill requires states receiving federal substance-use block grants to provide detailed information about their medication-assisted treatment (MAT) programs—specifically what drugs they use, how they prevent misuse, what misuse data they collect, and what drug-screening protocols they employ. States must report this information as part of their grant applications.

Why we flagged it

The bill is a straightforward amendment to existing grant-administration law that adds transparency and data-collection obligations. It does not create new funding, change eligibility, or alter treatment standards—only what states must report about their existing MAT programs.

What the text implies

• Increased federal data collection on MAT misuse may reveal significant diversion problems in some states, potentially triggering enforcement action or program restructuring.
• States with weak or absent drug-screening protocols will be exposed, creating political pressure to invest in screening infrastructure.
• Aggregated state data on MAT misuse and screening practices could inform national policy on opioid treatment standards and best practices.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill increases transparency and accountability in how states manage medication-assisted treatment, a critical tool for opioid addiction. Requiring states to report on drug types, misuse data, and screening protocols enables federal oversight, identifies gaps in diversion prevention, and creates a factual basis for improving treatment quality and safety across states.

Named in the bill

Public Health Service Act, Section 1932(b)(1)(A), State substance-use block grants, Medication-assisted treatment (MAT), Drug diversion prevention

Where it stands

• Sep 30, 2025 — Introduced · Congress.gov: “Introduced in House”
• Sep 30, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $360,000 in lobbying spend. A filing names 58 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Erin Houchin, the sponsor, reported $1,063,750 in PAC receipts in the 2026 cycle.

• American Psychological Association Services Inc.(fka American Psychological Assn — $340,000 on 1 filing
• Kelley Drye & Warren Llp Obo Tobacco-free Kids Action Fund — $20,000 on 1 filing

Lobbying Disclosure Act filings through Jul 16, 2026. A filing shows who paid to lobby on a bill it names, not what changed.